Abilify Maintena, a dopamine D2 partial agonist in once-monthly injectable form, for the maintenance treatment of schizophrenia in adult patients stabilised with oral Aripiprazole
Lundbeck and Otsuka Pharmaceutical have announced a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use ( CHMP ) recommending marketing authorisation f ...
read article